Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
about
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerChemotherapy and radiotherapy for inoperable advanced pancreatic cancerReview article: current treatment and optimal patient management in pancreatic cancer.Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells.Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer.Systemic therapy for metastatic pancreatic adenocarcinoma.Developments in the systemic therapy of pancreatic cancer.Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancerEfficacy of systemic therapy in advanced pancreatic carcinoma.A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer.Management of advanced pancreatic cancer.Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy.Pancreatic cancer. Evaluation of prognostic factors and treatment results.Intratumoral injection of an adriamycin immunoconjugate against human pancreatic cancer xenografts.
P2860
Q24240739-E5509800-4072-4851-9D96-E4E437976A8FQ24245085-A035A1C1-27A3-48BB-9171-CC206E1B5399Q30431857-68FD1951-8BD3-4F09-9C89-D6ABE868D670Q33338535-666E2326-723B-4119-AFB9-00C7616AD8CEQ33684453-54183416-75A6-4AF5-8845-9CCB0680EFBEQ34354462-124B76CB-1BEA-428B-84A6-1EC38B64D2E4Q34810745-D80A4BC8-8FA5-4305-9053-F5EB487E38A6Q35076238-D0C6E68E-7AC6-49A5-A156-786E12932545Q35087326-288DCBC0-E76B-4D00-A6E6-B8D901B7FAB3Q36114508-DB81068A-4C4C-4173-900B-49B875F2CB46Q36135201-3A55873F-2A98-41EA-8C79-F4B7149D630AQ36425154-E9409D64-C815-4B46-8B95-A81B46C03CAFQ36644189-5DE7FE75-77B2-4A31-8C0B-1D029A127034Q37960190-CB81BB31-100A-4204-9445-F60D4866D124Q40579509-A51D9609-9404-48E1-9218-5652809047A3Q42038899-0C428893-1477-459B-A895-D43D81B82697Q55026737-C4C77FFC-1029-427F-A813-C18CB9804A99
P2860
Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@ast
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@en
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@nl
type
label
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@ast
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@en
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@nl
prefLabel
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@ast
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@en
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@nl
P2093
P1433
P1476
Chemotherapy for advanced panc ...... ozotocin, and mitomycin (FSM).
@en
P2093
P356
10.1002/1097-0142(19860101)57:1<29::AID-CNCR2820570108>3.0.CO;2-L
P407
P577
1986-01-01T00:00:00Z